[Spondylodiskitis caused by Candida albicans. Report of two new cases]

F L Lado Lado1, I Villamil Cajoto, I Rodríguez Constenla

  • 1Servicio de Medicina Interna, Departamento de Medicina, Hospital Clínico Universitario de Santiago, Santiago de Compostela, A Coruña. flladol@usc.es

Anales De Medicina Interna (Madrid, Spain : 1984)
|May 19, 2005
PubMed

Insights

Candidiasis causing spondylodiskitis is rare, especially in individuals with HIV infection and intravenous drug use (IDU). This study details two such cases, highlighting key clinical, diagnostic, and therapeutic aspects of this uncommon fungal infection.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Spinal Infections

Background:

  • Candidiasis infections are increasing, linked to factors like immunodepression, catheters, and prolonged antibiotic therapy.
  • Spondylodiskitis, an infection of the spine and intervertebral discs, is rarely caused by Candida species.
  • Intravenous drug use (IDU) and Human Immunodeficiency Virus (HIV) infection are associated risk factors for invasive candidiasis.

Observation:

  • Two cases of spondylodiskitis caused by Candida albicans are presented.
  • Both patients were identified as intravenous drug users (IDUs) with a history of HIV infection.
  • Common symptoms included pain, fever, and a general constitutional syndrome.

Findings:

  • Candida albicans spondylodiskitis is a rare but serious complication in immunocompromised individuals, particularly those with HIV and a history of IDU.
  • Clinical presentation often involves significant pain, fever, and constitutional symptoms.
  • Diagnosis requires a high index of suspicion and appropriate microbiological and imaging studies.

Implications:

  • Increased awareness of rare fungal infections like Candida spondylodiskitis is crucial for timely diagnosis and treatment.
  • Understanding the risk factors, such as HIV and IDU, can guide preventative strategies and early intervention.
  • Effective management involves a multidisciplinary approach, combining antifungal therapy with surgical or conservative measures as indicated.

Related Concept Videos

Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...